دورية أكاديمية
National consensus on biologic dose reduction in psoriasis: a modified eDelphi procedure
العنوان: | National consensus on biologic dose reduction in psoriasis: a modified eDelphi procedure |
---|---|
المؤلفون: | L. S. van der Schoot, E. M. Baerveldt, W. A. van Enst, S. P. Menting, M. M. B. Seyger, S. L. Wanders, I. van Ee, A. H. Pieterse, J. M. P. A. van den Reek, E. M. G. J. de Jong |
المصدر: | Journal of Dermatological Treatment, Vol 0, Iss 0 (2022) |
بيانات النشر: | Taylor & Francis Group, 2022. |
سنة النشر: | 2022 |
المجموعة: | LCC:Dermatology |
مصطلحات موضوعية: | biologics, consensus, dose reduction, edelphi, psoriasis, Dermatology, RL1-803 |
الوصف: | Background Dose reduction of biologics for psoriasis is applied in daily practice, although guidelines are lacking. Striving for clear criteria is important, as it leads to a consistent application of dose reduction. Objective To achieve consensus on criteria for biologic dose reduction in psoriasis patients with stable and low disease activity. Methods An online Delphi procedure (eDelphi) was conducted. Dutch dermatologists were invited to participate in a maximum of 3 voting rounds. Proposed statements were selected based on literature review and included criteria for the application of dose reduction and dosing schedules. Biologic dose reduction was defined as ‘application of injection interval prolongation’. Proposed statements were rated using a 9-point Likert scale; consensus was reached when ≥70% of all voters rated ‘agree’ (7–9) and |
نوع الوثيقة: | article |
وصف الملف: | electronic resource |
اللغة: | English |
تدمد: | 0954-6634 1471-1753 09546634 |
Relation: | https://doaj.org/toc/0954-6634; https://doaj.org/toc/1471-1753 |
DOI: | 10.1080/09546634.2022.2154570 |
URL الوصول: | https://doaj.org/article/f6e04c0534d344b289ac07ae6b22201f |
رقم الأكسشن: | edsdoj.f6e04c0534d344b289ac07ae6b22201f |
قاعدة البيانات: | Directory of Open Access Journals |
تدمد: | 09546634 14711753 |
---|---|
DOI: | 10.1080/09546634.2022.2154570 |